Max Planck Society Seeks to Keep More Women as Faculty

The German research institution will invest more than $35 million in creating tenure-track positions for female scientists.

Written byKatarina Zimmer
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

ISTOCK, SANJERILast month (November 16), Germany’s renowned Max Planck Society launched a women-only hiring initiative to help tackle the underrepresentation of women in scientific research. Over the next four years, the society will put more than $35 million (€30 million) towards the “Lise Meitner excellence program”—named after the distinguished 20th-century chemist.

The program will create up to 10 positions for leading scientists. These will be tenure-track, meaning that participants will be given the chance to make their positions permanent at the end of the program.

A European Commission report in 2015 showed that while women represent nearly half of all PhD graduates, they represent only 21 percent of female researchers at the highest level.

Grietje Molema, president of the Dutch Network of Women Professors and a professor at the University of Groningen, tells Times Higher Education that affirmative action is an “essential part” of closing the gender gap in academic research, and explains that the number of such women-only programs is increasing in Europe. Max Planck’s program is a “good step forward,” she says.

Louise Morley, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • katya katarina zimmer

    After a year teaching an algorithm to differentiate between the echolocation calls of different bat species, Katarina decided she was simply too greedy to focus on one field of science and wanted to write about all of them. Following an internship with The Scientist in 2017, she’s been happily freelancing for a number of publications, covering everything from climate change to oncology. Katarina is a news correspondent for The Scientist and contributes occasional features to the magazine. Find her on Twitter @katarinazimmer and read her work on her website.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies